Who
Conor Kilroy
Officer
Company insider
Files Form 4 as: General Counsel and Secretary, Aura Biosciences; SVP, GC & Secretary, Ironwood Pharmaceuticals.
In numbers
- Trades disclosed
- 24
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $406K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 24 Apr 2020
- Last trade
- 1 Jul 2026
- Last filed
- 1 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 1 Jul 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —14,858 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —14,858 at $0.00 | filing |
| 16 Apr 2026filed 16 Apr 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $82K11,738 at $7.02 | filing |
| 16 Apr 2026filed 16 Apr 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $82K11,738 at $7.02 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —62,339 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —112,661 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —112,661 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —62,339 at $0.00 | filing |
| 17 Feb 2026filed 17 Feb 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $61K12,079 at $5.05 | filing |
| 17 Feb 2026filed 17 Feb 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $61K12,079 at $5.05 | filing |
| 16 Apr 2025filed 16 Apr 2025 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $39K7,162 at $5.49 | filing |
| 3 Feb 2025filed 4 Feb 2025 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —59,525 at $0.00 | filing |
| 3 Feb 2025filed 4 Feb 2025 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —90,475 at $0.00 | filing |
| 2 Apr 2024filed 4 Apr 2024 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —144,000 at $0.00 | filing |
| 2 Apr 2024filed 4 Apr 2024 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —96,000 at $0.00 | filing |
| 26 Feb 2021filed 2 Mar 2021 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $13K1,399 at $9.11 | filing |
| 26 Feb 2021filed 2 Mar 2021 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $13K1,474 at $9.11 | filing |
| 26 Feb 2021filed 2 Mar 2021 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $21K2,268 at $9.11 | filing |
| 26 Feb 2021filed 2 Mar 2021 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $17K1,848 at $9.11 | filing |
| 9 Nov 2020filed 10 Nov 2020 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $6,541599 at $10.92 | filing |
News
No headline names them, or the companies they trade most, lately.